Global Pain Management Drugs Market 2018-2022

Below are some of the key findings from the pain management drugs market analysis:

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global Pain Management Drugs Industry Overview

The strong pipeline and recently approvals of pain management drugs will emerge as one of the critical reasons that will propel the pain management drugs market in the next five years. Pain management pipelines test newer targeted drugs for chronic conditions such as post-operative pain, lower back pain, migraine headache, osteoarthritis, acute pain, and others. Opioid receptor ligands, substance P and neurokinin receptor antagonists, glutamate receptor antagonists, nitric oxide-based analgesics are some of the drugs that are in the development phase.

New drug delivery systems are favoring the rate-controlled and target-specific approaches. This leads to the availability of better pain management treatment options. This will drive the pain management drugs market to grow at a CAGR of nearly 4% during the forecast period. Fasinumab, Secukinumab, Galcanezumab, and Fremanezumab are some of the novel abuse-deterrent opioids and monoclonal antibodies for pain management.

Top pain management drugs companies covered in this market research report

The pain management drugs market is fragmented. These players are leveraging advanced technologies to offer effective pain management. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this pain management drugs industry analysis report will allow the clients to identify new growth opportunities and design innovative strategies to improve their share in the market.

The report offers a complete analysis of various companies including:

• Endo Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson
• Pfizer

Pain management drugs market segmentation based on geographic regions

• Americas
• APAC
• EMEA

With a complete study of the growth opportunities for companies, the Americas will contribute to the highest market share of this market throughout the forecast period.  The increasing prevalence of chronic pain conditions is one of the major reasons for high growth of the pain management drugs market in this region.

Pain management drugs market segmentation based on product

• Opioids
• NSAIDs
• Others

The opioids segment will account for the highest market share in the pain management drugs market as opioids are the most potent drugs for the treatment of severe pain conditions such as cancer pain.

Key highlights of the global pain management drugs market for the forecast years 2018-2022:

• CAGR of the market during the forecast period 2018-2022
• Detailed information on factors that will accelerate the growth of the pain management drugs market during the next five years
• Precise estimation of the global pain management drugs market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the pain management drugs industry across various geographies such as the Americas, APAC, and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive information about factors that will challenge the growth of pain management drugs companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch